UNSPSC 51171717: Mebiquine

This classification denotes an antidiarrheal agent with the molecular formula C10H10BiNO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier DBE10Q8QF6, chemically known as quinoline, 8-((dihydroxybismuthino)oxy)-6-methyl- but generally known as mebiquine, which bears US NIH Compound Identifier 16683098. European Medicines Agency schedules Mebiquine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08665MIG. The term MEBIQUINE is an International Non-Proprietary Name.

UNSPSC 51171717 Mefloquine, a Commodity code, does not align with recent state and local procurement activity under this classification. Collin County Community Supervision and Corrections Department posted the sole recent opportunity tagged to this code — RFP 2026-327 for offender specimen collection and drug testing services, due July 23, 2026 — which encompasses staffing of collection sites, immunoassay and confirmatory testing (LC/MS/MS or GC/MS), oral fluid and hair testing methodologies, electronic result reporting, and Interactive Voice Response notification systems. The scope reflects laboratory drug-screening operations and facility staffing rather than pharmaceutical procurement. The code's nominal scope (mefloquine, an antimalarial medication) bears no relation to the actual work being solicited.

Collin County, Texas is the sole issuing body represented in recent activity under this code. The estimated contract value is $600,000 annually across approximately 25,031 tests (five-panel and six-panel immunoassay screens plus ancillary testing), with a two-year initial term commencing September 1, 2026 and three optional one-year renewals. The successful vendor must hold SAMHSA, Texas DPS, or CAP laboratory certification and maintain collection operations at sites in Plano and McKinney during standard business hours plus five Saturdays annually. Evaluation criteria weight vendor understanding and qualifications (55 points combined), client references (15 points), and cost (30 points), with optional Phase 2 demonstrations and interviews worth up to 30 additional points. The code shows minimal activity and a categorical mismatch; firms pursuing laboratory services, offender screening, or criminal-justice testing should monitor corrections and community supervision procurement channels rather than rely on this UNSPSC classification.